Related Experiment Videos
[3H]PN200-110 and [3H]glibenclamide binding in normal and cardiomyopathic hamsters
J A Miller1, P A Chmielewski, D Rampe
1Marion Merrell Dow Research Institute, Cincinnati, OH 45215.
Insights
Cardiomyopathic hamsters show altered calcium (Ca2+) and potassium (K+) channel binding in the heart and brain. These changes in ion channel activity may contribute to the disease progression in this animal model.
Area of Science:
- Cardiovascular Research
- Neuroscience
- Pharmacology
Background:
- Cardiomyopathy involves cardiac dysfunction, and ion channel alterations are implicated.
- Calcium (Ca2+) and ATP-sensitive potassium (K+) channels play critical roles in cardiac and neuronal function.
Purpose of the Study:
- To investigate alterations in Ca2+ and K+ channel ligand binding in the hearts and brains of cardiomyopathic hamsters.
- To compare binding site densities between diseased and control animals at different ages.
Main Methods:
- Radioligand binding assays using [3H]PN200-110 (Ca2+ channel ligand) and [3H]glibenclamide (K+ channel ligand).
- Quantitative autoradiography was employed to analyze binding patterns in specific brain regions.
Main Results:
- Elevated [3H]PN200-110 binding site density in the hearts of cardiomyopathic hamsters at 30 and 180 days.
- [3H]Glibenclamide binding site density was significantly reduced in the hearts of 180-day old cardiomyopathic hamsters.
- Increased [3H]glibenclamide binding observed in several brain areas of 30-day old cardiomyopathic hamsters.
Conclusions:
- The cardiomyopathic hamster model exhibits significant alterations in both Ca2+ and K+ channel binding.
- These findings suggest a role for dysregulated ion channel function in the pathophysiology of this form of cardiomyopathy.
Abstract:
1. We examined the binding of the Ca2+ channel ligand [3H]PN200-110 and the ATP-sensitive K+ channel ligand [3H]glibenclamide to brain and heart from cardiomyopathic hamsters and compared them to controls. 2. We found that [3H]PN200-110 binding site density was elevated in the heart, but not in the brain, of 30- and 180-day old cardiomyopathic hamsters when compared to controls. 3. [3H]Glibenclamide binding site density was greatly reduced in the heart of 180-day old cardiomyopathic animals compared with all other groups. 4. Quantitative autoradiography revealed that [3H]glibenclamide binding was elevated in several brain areas of 30-day old cardiomyopathic hamsters relative to controls. 5. It is concluded that alterations in both Ca2+ and K+ channels exist in the cardiomyopathic hamster.